Blastic plasmacytoid dendritic cell neoplasm (BPDCN) in leukaemic phase without skin lesions: a diagnostic and management challenge

Pathology. 2019 Jun;51(4):439-441. doi: 10.1016/j.pathol.2018.11.016. Epub 2019 Apr 16.

Authors

Nicholas Murphy¹, Daniel Owens², Emily Hinds³, Niles Nelson⁴

Affiliations

¹ Department Haematology, Royal Hobart Hospital, Hobart, Tas, Australia. Electronic address: nick.murphy@ths.tas.gov.au.
² Hobart Pathology, Hobart, Tas, Australia.
³ Special Diagnostics, Department Pathology, Royal Hobart Hospital, Tas, Australia.
⁴ Department Haematology, Royal Hobart Hospital, Hobart, Tas, Australia.

PMID: 31003841
DOI: 10.1016/j.pathol.2018.11.016

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Bone Marrow / pathology
Dendritic Cells / pathology*
Fatal Outcome
Female
Hematologic Neoplasms / diagnosis*
Hematologic Neoplasms / drug therapy
Hematologic Neoplasms / pathology
Humans
Leukemia / diagnosis*
Leukemia / drug therapy
Leukemia / pathology